Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 518

1.

A proteome-scale map of the human interactome network.

Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X, Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis AR, Convery-Zupan D, Corominas R, Coulombe-Huntington J, Dann E, Dreze M, Dricot A, Fan C, Franzosa E, Gebreab F, Gutierrez BJ, Hardy MF, Jin M, Kang S, Kiros R, Lin GN, Luck K, MacWilliams A, Menche J, Murray RR, Palagi A, Poulin MM, Rambout X, Rasla J, Reichert P, Romero V, Ruyssinck E, Sahalie JM, Scholz A, Shah AA, Sharma A, Shen Y, Spirohn K, Tam S, Tejeda AO, Trigg SA, Twizere JC, Vega K, Walsh J, Cusick ME, Xia Y, Barabási AL, Iakoucheva LM, Aloy P, De Las Rivas J, Tavernier J, Calderwood MA, Hill DE, Hao T, Roth FP, Vidal M.

Cell. 2014 Nov 20;159(5):1212-26. doi: 10.1016/j.cell.2014.10.050.

PMID:
25416956
[PubMed - in process]
2.

IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma.

Marie-Cardine A, Viaud N, Thonnart N, Joly R, Chanteux S, Gauthier L, Bonnafous C, Rossi B, Bléry M, Paturel C, Bensussan A, Bagot M, Sicard H.

Cancer Res. 2014 Nov 1;74(21):6060-70. doi: 10.1158/0008-5472.CAN-14-1456.

PMID:
25361998
[PubMed - indexed for MEDLINE]
3.

KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse.

Babor F, Manser AR, Fischer JC, Scherenschlich N, Enczmann J, Chazara O, Moffett A, Borkhardt A, Meisel R, Uhrberg M.

Blood. 2014 Oct 2;124(14):2248-51. doi: 10.1182/blood-2014-05-572065. Epub 2014 Aug 27.

PMID:
25163702
[PubMed - indexed for MEDLINE]
4.

KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.

Nemat-Gorgani N, Edinur HA, Hollenbach JA, Traherne JA, Dunn PP, Chambers GK, Parham P, Norman PJ.

Immunogenetics. 2014 Nov;66(11):597-611. doi: 10.1007/s00251-014-0794-1. Epub 2014 Aug 21.

PMID:
25139336
[PubMed - indexed for MEDLINE]
5.

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.

Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF.

J Neuroimmunol. 2014 Sep 15;274(1-2):174-9. doi: 10.1016/j.jneuroim.2014.06.024. Epub 2014 Jul 6.

PMID:
25037176
[PubMed - indexed for MEDLINE]
6.

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression.

Wright PW, Li H, Huehn A, O'Connor GM, Cooley S, Miller JS, Anderson SK.

Genes Immun. 2014 Oct;15(7):440-8. doi: 10.1038/gene.2014.34. Epub 2014 Jul 3.

PMID:
24989671
[PubMed - in process]
7.

The aberrant expression of stimulatory and inhibitory killer immunoglobulin-like receptors in NK- and NKT-cells contributes to lupus.

Bai Y, Zhang Y, Yang Q, Hou Y, Hu N, Wang D, Sun H.

Clin Lab. 2014;60(5):717-27.

PMID:
24839813
[PubMed - indexed for MEDLINE]
8.

Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma.

Dutta A, Saikia N, Phookan J, Baruah MN, Baruah S.

Immunogenetics. 2014 Aug;66(7-8):439-48. doi: 10.1007/s00251-014-0778-1. Epub 2014 May 13.

PMID:
24818561
[PubMed - indexed for MEDLINE]
9.

Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.

van Teijlingen NH, Hölzemer A, Körner C, García-Beltrán WF, Schafer JL, Fadda L, Suscovich TJ, Brander C, Carrington M, Evans DT, van Baarle D, Altfeld M.

AIDS. 2014 Jun 19;28(10):1399-408. doi: 10.1097/QAD.0000000000000284.

PMID:
24785948
[PubMed - indexed for MEDLINE]
10.

Maternal KIR in combination with paternal HLA-C2 regulate human birth weight.

Hiby SE, Apps R, Chazara O, Farrell LE, Magnus P, Trogstad L, Gjessing HK, Carrington M, Moffett A.

J Immunol. 2014 Jun 1;192(11):5069-73. doi: 10.4049/jimmunol.1400577. Epub 2014 Apr 28.

PMID:
24778445
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.

Vejbaesya S, Sae-Tam P, Khuhapinant A, Srinak D.

Hum Immunol. 2014 Jul;75(7):673-6. doi: 10.1016/j.humimm.2014.04.004. Epub 2014 Apr 19.

PMID:
24755352
[PubMed - indexed for MEDLINE]
12.

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.

Giebel S, Boratyn-Nowicka A, Karabon L, Jedynak A, Pamula-Pilat J, Tecza K, Kula D, Kowal M, Frydecka I, Grzybowska E.

Hum Immunol. 2014 Jun;75(6):508-13. doi: 10.1016/j.humimm.2014.04.002. Epub 2014 Apr 19.

PMID:
24755350
[PubMed - indexed for MEDLINE]
13.

Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility.

Ben Fredj N, Rizzo R, Bortolotti D, Nefzi F, Chebel S, Rotola A, Frih-Ayed M, Di Luca D, Aouni M.

J Neuroimmunol. 2014 Jun 15;271(1-2):30-5. doi: 10.1016/j.jneuroim.2014.03.017. Epub 2014 Mar 30.

PMID:
24735502
[PubMed - indexed for MEDLINE]
14.

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

Roberts CH, Molina S, Makalo P, Joof H, Harding-Esch EM, Burr SE, Mabey DC, Bailey RL, Burton MJ, Holland MJ.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2744. doi: 10.1371/journal.pntd.0002744. eCollection 2014 Mar.

PMID:
24651768
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The presence of KIR2DS5 confers protection against adult immune thrombocytopenia.

Seymour LA, Nourse JP, Crooks P, Wockner L, Bird R, Tran H, Gandhi MK.

Tissue Antigens. 2014 Mar;83(3):154-60. doi: 10.1111/tan.12295. Epub 2014 Feb 12.

PMID:
24571473
[PubMed - indexed for MEDLINE]
16.

Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.

O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, Anderson SK, Price DA, Brooks AG, Rossjohn J, McVicar DW.

J Immunol. 2014 Mar 15;192(6):2875-84. doi: 10.4049/jimmunol.1303142. Epub 2014 Feb 21.

PMID:
24563253
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The role of KIR2DS1 in multiple sclerosis--KIR in Portuguese MS patients.

Bettencourt A, Silva AM, Carvalho C, Leal B, Santos E, Costa PP, Silva BM.

J Neuroimmunol. 2014 Apr 15;269(1-2):52-5. doi: 10.1016/j.jneuroim.2014.01.009. Epub 2014 Jan 28.

PMID:
24529855
[PubMed - indexed for MEDLINE]
18.

Role of KIR genes and genotypes in susceptibility to or protection against hepatitis B virus infection in a Turkish cohort.

Kibar F, Goruroglu Ozturk O, Ulu A, Erken E, Inal S, Dinkci S, Kurtaran B, Tasova Y, Aksu HS, Yaman A.

Med Sci Monit. 2014 Jan 10;20:28-34. doi: 10.12659/MSM.889893.

PMID:
24407110
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome.

Blum S, Csurhes P, Reddel S, Spies J, McCombe P.

J Neuroimmunol. 2014 Feb 15;267(1-2):92-6. doi: 10.1016/j.jneuroim.2013.12.007. Epub 2013 Dec 12.

PMID:
24367901
[PubMed - indexed for MEDLINE]
20.

KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.

Nozawa Y, Umemura T, Joshita S, Katsuyama Y, Shibata S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E, Ota M.

PLoS One. 2013 Dec 12;8(12):e83381. doi: 10.1371/journal.pone.0083381. eCollection 2013.

PMID:
24349500
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk